| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 4.0227 | 16 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 4.2288 | 22 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 3.87522 | 13 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 4.04222 | 16 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 4.03443 | 17 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 3.99813 | 17 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 3.61601 | 6 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 4.23149 | 22 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 4.4315 | 27 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 4.17786 | 21 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 4.12411 | 20 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 3.92292 | 14 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 3.88724 | 13 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 3.75807 | 11 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 3.95038 | 16 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 3.97013 | 16 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 3.9308 | 15 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 3.86816 | 13 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 3.8218 | 11 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 3.9397 | 13 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 4.22973 | 22 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 3.89316 | 14 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 4.19279 | 23 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 4.17439 | 21 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 3.92343 | 14 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 3.58231 | 6 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 3.84799 | 12 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.26063 | 23 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 4.49279 | 29 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 3.76886 | 9 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 3.83328 | 12 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 3.74243 | 10 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 4.2972 | 23 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 4.20311 | 22 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 3.83106 | 12 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 3.72745 | 10 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 3.84933 | 12 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 4.12457 | 19 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 4.1661 | 20 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 3.89 | 14 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 3.97587 | 15 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 3.8815 | 13 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 3.73018 | 9 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 3.72329 | 10 |